To include your compound in the COVID-19 Resource Center, submit it here.

Oral budesonide suspension: Phase IIb data

The double-blind, U.S. Phase IIb PEER trial in 71 evaluable patients ages 2-18 showed that mid- and high-dose daily OBS met the primary endpoint of a significantly greater proportion

Read the full 291 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE